Comprehensive genomic profiling reveals molecular subsets of ASXL1-mutated myeloid neoplasms.
Saved in:
| Title: | Comprehensive genomic profiling reveals molecular subsets of ASXL1-mutated myeloid neoplasms. |
|---|---|
| Authors: | Johnson SM; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA., Haberberger J; Foundation Medicine, Inc, Cambridge, MA, USA., Galeotti J; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA., Ramkissoon L; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA., Coombs CC; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; UC Irvine, Irvine, CA, USA., Richardson DR; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Foster MC; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Novartis Pharmaceuticals, Cambridge, MA, USA., Duncan D; Foundation Medicine, Inc, Cambridge, MA, USA.; GRAIL, Inc, Durham, NC, USA., Montgomery ND; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; NeoGenomics Laboratories, Aliso Viejo, CA, USA., Ferguson NL; Foundation Medicine, Inc, Cambridge, MA, USA., Zeidner JF; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2024 Feb; Vol. 65 (2), pp. 209-218. Date of Electronic Publication: 2024 Jan 24. |
| Publication Type: | Review; Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37921062 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Comprehensive genomic profiling reveals molecular subsets of ASXL1-mutated myeloid neoplasms. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Johnson+SM%22">Johnson SM</searchLink>; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Haberberger+J%22">Haberberger J</searchLink>; Foundation Medicine, Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Galeotti+J%22">Galeotti J</searchLink>; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Ramkissoon+L%22">Ramkissoon L</searchLink>; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Coombs+CC%22">Coombs CC</searchLink>; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; UC Irvine, Irvine, CA, USA.<br /><searchLink fieldCode="AU" term="%22Richardson+DR%22">Richardson DR</searchLink>; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Foster+MC%22">Foster MC</searchLink>; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Novartis Pharmaceuticals, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Duncan+D%22">Duncan D</searchLink>; Foundation Medicine, Inc, Cambridge, MA, USA.; GRAIL, Inc, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Montgomery+ND%22">Montgomery ND</searchLink>; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; NeoGenomics Laboratories, Aliso Viejo, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ferguson+NL%22">Ferguson NL</searchLink>; Foundation Medicine, Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Zeidner+JF%22">Zeidner JF</searchLink>; Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2024 Feb; Vol. 65 (2), pp. 209-218. <i>Date of Electronic Publication: </i>2024 Jan 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Review; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37921062 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2023.2277672 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 209 Titles: – TitleFull: Comprehensive genomic profiling reveals molecular subsets of ASXL1-mutated myeloid neoplasms. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Johnson SM – PersonEntity: Name: NameFull: Haberberger J – PersonEntity: Name: NameFull: Galeotti J – PersonEntity: Name: NameFull: Ramkissoon L – PersonEntity: Name: NameFull: Coombs CC – PersonEntity: Name: NameFull: Richardson DR – PersonEntity: Name: NameFull: Foster MC – PersonEntity: Name: NameFull: Duncan D – PersonEntity: Name: NameFull: Montgomery ND – PersonEntity: Name: NameFull: Ferguson NL – PersonEntity: Name: NameFull: Zeidner JF IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2024 Feb Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1029-2403 Numbering: – Type: volume Value: 65 – Type: issue Value: 2 Titles: – TitleFull: Leukemia & lymphoma Type: main |
| ResultId | 1 |